NASDAQ:OGI Organigram Global (OGI) Stock Price, News & Analysis $0.93 +0.02 (+1.64%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$0.91 -0.03 (-2.86%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Organigram Global Stock (NASDAQ:OGI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Organigram Global alerts:Sign Up Key Stats Today's Range$0.90▼$0.9450-Day Range$0.87▼$1.1452-Week Range$0.85▼$2.24Volume197,994 shsAverage Volume402,719 shsMarket Capitalization$131.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Organigram Global Inc. (NASDAQ: OGI) is a licensed producer of cannabis and hemp products headquartered in Moncton, New Brunswick, Canada. Founded in 2013, the company operates a state-of-the-art cultivation and manufacturing facility spanning more than one million square feet. Organigram holds licenses from Health Canada to produce and sell both medical and adult-use cannabis, and it pursues Good Manufacturing Practice (GMP) certification to support international exports. The company’s product portfolio encompasses dried flower, pre-rolled joints, cannabis oils, capsules and soft gels, as well as vapourizer cartridges and extracts. Organigram distributes under a variety of brands, including Monjour, Edison and First Growth, targeting diverse consumer segments from value-focused to premium. Its cultivation methods combine indoor and greenhouse systems with automated processes designed to ensure product consistency, safety and quality. Organigram serves markets across Canada and has established partnerships to access select international markets in jurisdictions that recognize Canadian GMP certification. The company’s leadership team is led by Chief Executive Officer Greg Engel, who has guided Organigram through its public listings on the Toronto Stock Exchange and the Nasdaq in 2020. Under his management, Organigram has focused on innovation in product formats, efficiency in cultivation, and strategic brand development to navigate the evolving regulatory landscape.AI Generated. May Contain Errors. Read More Organigram Global Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreOGI MarketRank™: Organigram Global scored higher than 19% of companies evaluated by MarketBeat, and ranked 768th out of 836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingOrganigram Global has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageOrganigram Global has only been the subject of 1 research reports in the past 90 days.Read more about Organigram Global's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-55.56% Earnings GrowthEarnings for Organigram Global are expected to decrease by -55.56% in the coming year, from $0.09 to $0.04 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram Global is -7.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram Global is -7.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrganigram Global has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Organigram Global's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.74% of the float of Organigram Global has been sold short.Short Interest Ratio / Days to CoverOrganigram Global has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.Change versus previous monthShort interest in Organigram Global has recently increased by 11.99%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOrganigram Global does not currently pay a dividend.Dividend GrowthOrganigram Global does not have a long track record of dividend growth. News and Social Media4.5 / 5News Sentiment1.19 News SentimentOrganigram Global has a news sentiment score of 1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Organigram Global this week, compared to 2 articles on an average week.Search Interest4 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows11 people have added Organigram Global to their MarketBeat watchlist in the last 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Organigram Global insiders have not sold or bought any company stock.Percentage Held by Insiders0.09% of the stock of Organigram Global is held by insiders.Percentage Held by Institutions34.63% of the stock of Organigram Global is held by institutions.Read more about Organigram Global's insider trading history. Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram Global and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OGI Stock News HeadlinesSanity Group Acquisition Boosts Organigram's Quarterly RevenueJuly 26 at 9:24 AM | seekingalpha.comOrganigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market ShareJuly 20, 2026 | financialpost.comFTrump’s emergency dollar resetBloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this century — and the consequences for your savings and investments could be severe. President Trump has signed executive order 14241 to initiate the first full reset of the American dollar in 50 years. A new monetary anchor is being established — one that's not gold or crypto, but something far more unexpected that Vladimir Putin once called the key to world leadership.July 26 at 1:00 AM | Porter & Company (Ad)Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market ShareJuly 20, 2026 | businesswire.comOrganigram Global Inc (OGI) Raises 2026 Guidance on Sanity AcquisitionMay 31, 2026 | insidermonkey.comOrganigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...May 13, 2026 | finance.yahoo.comTranscript: OrganiGram Holdings Q2 2026 Earnings Conference CallMay 13, 2026 | uk.finance.yahoo.comOrganiGram Holdings Reports Q2 2026 Results: Full Earnings Call TranscriptMay 13, 2026 | uk.finance.yahoo.comSee More Headlines OGI Stock Analysis - Frequently Asked Questions How have OGI shares performed this year? Organigram Global's stock was trading at $1.68 on January 1st, 2026. Since then, OGI shares have decreased by 44.4% and is now trading at $0.9347. How were Organigram Global's earnings last quarter? Organigram Global Inc. (NASDAQ:OGI) issued its earnings results on Tuesday, May, 12th. The company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). The business had revenue of $42.99 million for the quarter, compared to analysts' expectations of $50.56 million. Organigram Global had a negative net margin of 9.22% and a negative trailing twelve-month return on equity of 13.41%. Read the conference call transcript. When did Organigram Global's stock split? Organigram Global's stock reverse split before market open on Friday, July 7th 2023.The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. How do I buy shares of Organigram Global? Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Organigram Global own? Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram Global investors own include i3 Verticals (IIIV), Ford Motor (F), Lucid Group (LCID), Trade Desk (TTD), Finance of America Companies (FOA), NVIDIA (NVDA) and Company Calendar Last Earnings5/12/2026Today7/26/2026Next Earnings (Estimated)8/11/2026Fiscal Year End9/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 OGI's financial health is in the Red zone, according to TradeSmith. OGI has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:OGI CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees1,139Year Founded2013Profitability EPS (Trailing Twelve Months)($0.13) Trailing P/E RatioN/A Forward P/E Ratio10.39 P/E GrowthN/ANet Income-$17.70 million Net Margins-9.22% Pretax Margin-13.68% Return on Equity-13.41% Return on Assets-9.09% Debt Debt-to-Equity RatioN/A Current Ratio2.82 Quick Ratio1.30 Sales & Book Value Annual Sales$185.07 million Price / Sales0.71 Cash FlowN/A Price / Cash FlowN/A Book Value$1.86 per share Price / Book0.50Miscellaneous Outstanding Shares140,980,000Free Float140,848,000Market Cap$131.77 million OptionableOptionable Beta1.45 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:OGI) was last updated on 7/26/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredThe pact that ran the world and dollar just expiredIn 1974, a U.S.-Saudi deal tied oil sales exclusively to dollars, forcing nations worldwide to hold dollars an...Golden Portfolio | SponsoredThe invention Elon called the greatest in historyJeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...Brownstone Research | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OGI Stock Alerts